mortality/aging
• average lifespan 96 days
|
nervous system
N |
• no inclusion bodies were found in the spinal cord and brains
|
microgliosis
(
J:198242
)
• in various regions of the brain, uniformly distributed
|
• in the thalamus, pons, corpus callosum and cerebellar white matter without apoptosis
|
astrocytosis
(
J:198242
)
• the thalamus, corpus callosum, brain stem and spinal cord
|
• spinal cords contain inclusion material
|
behavior/neurological
• less habituation than wild-type mice
|
• at 12 weeks, mice exhibit increased foot slips on a 5mm squared round beam compared with wild-type mice
• mice exhibit fewer foot slips on a round beam compared with Psaptm2Suz homozygotes
• however, mice exhibit no significant latency to cross beam
|
• locomotor defects between 61 and 88 days
|
• in the periphery especially at 12 weeks
|
• in the central regions at 8 and 12 weeks
|
immune system
microgliosis
(
J:198242
)
• in various regions of the brain, uniformly distributed
|
liver/biliary system
• engorged storage macrophages in the liver at greater than 4 weeks
|
renal/urinary system
• storage bodies in the distal tubules of the kidney
|
cardiovascular system
• membrane inclusion bodies are found in vascular endothelial cells in the spinal cords
|
cellular
• increased autophagy in the brain
|
growth/size/body
weight loss
(
J:198242
)
• with onset of motor defects
|
hematopoietic system
microgliosis
(
J:198242
)
• in various regions of the brain, uniformly distributed
|
homeostasis/metabolism
• increased autophagy in the brain
|
• in the thalamus, pons, corpus callosum and cerebellar white matter without apoptosis
|
• abnormal glycosphingolipid metabolism with substantial increases in lactosylceramide in the liver, sulfatide accumulation in the brain and kidneys and decreased galctosylsphingosine in the brain
|